Michael Cripps
Concepts (370)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholecystectomy, Laparoscopic | 8 | 2023 | 54 | 3.670 |
Why?
| | Cholecystitis, Acute | 7 | 2024 | 24 | 2.740 |
Why?
| | Wounds and Injuries | 19 | 2026 | 957 | 2.660 |
Why?
| | Cholecystitis | 5 | 2023 | 23 | 2.040 |
Why?
| | Trauma Centers | 20 | 2026 | 462 | 1.870 |
Why?
| | Venous Thromboembolism | 6 | 2025 | 324 | 1.700 |
Why?
| | Severity of Illness Index | 7 | 2024 | 2925 | 1.300 |
Why?
| | Hemorrhage | 10 | 2026 | 809 | 1.230 |
Why?
| | Anticoagulants | 7 | 2025 | 724 | 1.210 |
Why?
| | Appendicitis | 4 | 2020 | 148 | 1.180 |
Why?
| | Emergency Treatment | 2 | 2020 | 124 | 1.100 |
Why?
| | Retrospective Studies | 45 | 2026 | 17101 | 0.970 |
Why?
| | Cholecystectomy | 4 | 2024 | 59 | 0.930 |
Why?
| | Postoperative Complications | 7 | 2021 | 2920 | 0.910 |
Why?
| | Resuscitation | 9 | 2024 | 302 | 0.880 |
Why?
| | Appendectomy | 3 | 2020 | 89 | 0.800 |
Why?
| | Injury Severity Score | 14 | 2026 | 600 | 0.790 |
Why?
| | Thrombelastography | 4 | 2021 | 178 | 0.750 |
Why?
| | Enoxaparin | 4 | 2023 | 67 | 0.750 |
Why?
| | Blood Coagulation | 3 | 2021 | 268 | 0.750 |
Why?
| | Adult | 52 | 2026 | 40506 | 0.740 |
Why?
| | Middle Aged | 46 | 2026 | 35928 | 0.690 |
Why?
| | Simulation Training | 2 | 2022 | 134 | 0.670 |
Why?
| | Burns | 4 | 2023 | 377 | 0.670 |
Why?
| | Operative Time | 7 | 2023 | 175 | 0.670 |
Why?
| | Abdomen | 2 | 2018 | 141 | 0.660 |
Why?
| | Length of Stay | 9 | 2026 | 1337 | 0.650 |
Why?
| | Rib Fractures | 1 | 2021 | 33 | 0.650 |
Why?
| | Time-to-Treatment | 2 | 2020 | 245 | 0.650 |
Why?
| | Laparoscopy | 3 | 2022 | 475 | 0.640 |
Why?
| | Blood Transfusion | 4 | 2026 | 405 | 0.640 |
Why?
| | Prospective Studies | 19 | 2025 | 7997 | 0.640 |
Why?
| | Humans | 89 | 2026 | 144957 | 0.630 |
Why?
| | Shock, Hemorrhagic | 5 | 2024 | 201 | 0.610 |
Why?
| | Machine Learning | 2 | 2023 | 587 | 0.610 |
Why?
| | Critical Pathways | 1 | 2021 | 108 | 0.600 |
Why?
| | Nerve Block | 1 | 2021 | 103 | 0.600 |
Why?
| | Pain Management | 2 | 2021 | 405 | 0.600 |
Why?
| | Data Interpretation, Statistical | 1 | 2021 | 372 | 0.600 |
Why?
| | Male | 58 | 2026 | 72406 | 0.580 |
Why?
| | Emergency Medical Services | 2 | 2023 | 696 | 0.580 |
Why?
| | Balloon Occlusion | 3 | 2024 | 39 | 0.580 |
Why?
| | Specialties, Surgical | 1 | 2020 | 82 | 0.570 |
Why?
| | Artificial Intelligence | 1 | 2023 | 367 | 0.570 |
Why?
| | Kaolin | 1 | 2018 | 5 | 0.570 |
Why?
| | Factor Xa | 1 | 2018 | 35 | 0.570 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2019 | 38 | 0.570 |
Why?
| | Female | 60 | 2026 | 78376 | 0.570 |
Why?
| | Elective Surgical Procedures | 1 | 2020 | 201 | 0.560 |
Why?
| | Vitamin K | 1 | 2018 | 45 | 0.560 |
Why?
| | Airway Extubation | 1 | 2018 | 60 | 0.540 |
Why?
| | Hemostatics | 1 | 2018 | 61 | 0.540 |
Why?
| | End Stage Liver Disease | 1 | 2019 | 94 | 0.530 |
Why?
| | Embolization, Therapeutic | 3 | 2024 | 242 | 0.530 |
Why?
| | Tachycardia, Supraventricular | 1 | 2017 | 45 | 0.510 |
Why?
| | Practice Guidelines as Topic | 5 | 2026 | 1563 | 0.510 |
Why?
| | Atrial Flutter | 1 | 2017 | 45 | 0.510 |
Why?
| | Appendix | 1 | 2017 | 31 | 0.500 |
Why?
| | Pneumonia, Ventilator-Associated | 3 | 2026 | 57 | 0.490 |
Why?
| | Internship and Residency | 4 | 2022 | 1257 | 0.490 |
Why?
| | Pulmonary Embolism | 1 | 2019 | 244 | 0.480 |
Why?
| | Clinical Trials as Topic | 1 | 2021 | 1054 | 0.480 |
Why?
| | Orthopedic Procedures | 1 | 2019 | 243 | 0.470 |
Why?
| | Algorithms | 1 | 2023 | 1839 | 0.460 |
Why?
| | Texas | 5 | 2019 | 278 | 0.450 |
Why?
| | Predictive Value of Tests | 6 | 2024 | 2118 | 0.440 |
Why?
| | Patient Safety | 1 | 2018 | 349 | 0.440 |
Why?
| | Biomedical Research | 1 | 2021 | 710 | 0.430 |
Why?
| | Treatment Outcome | 17 | 2024 | 11695 | 0.420 |
Why?
| | Critical Illness | 2 | 2019 | 892 | 0.420 |
Why?
| | Endovascular Procedures | 3 | 2024 | 384 | 0.420 |
Why?
| | Aged | 22 | 2025 | 25947 | 0.400 |
Why?
| | Surgeons | 3 | 2025 | 340 | 0.390 |
Why?
| | Hospitalization | 3 | 2022 | 2434 | 0.380 |
Why?
| | Clinical Competence | 3 | 2026 | 1244 | 0.370 |
Why?
| | Wounds, Nonpenetrating | 2 | 2026 | 316 | 0.350 |
Why?
| | Mass Screening | 4 | 2023 | 1348 | 0.350 |
Why?
| | Liver | 3 | 2024 | 1888 | 0.340 |
Why?
| | Atrial Fibrillation | 1 | 2017 | 550 | 0.340 |
Why?
| | Hand-Assisted Laparoscopy | 1 | 2010 | 4 | 0.320 |
Why?
| | Wandering Spleen | 1 | 2010 | 2 | 0.320 |
Why?
| | Operating Rooms | 3 | 2022 | 146 | 0.300 |
Why?
| | Reproducibility of Results | 6 | 2021 | 3415 | 0.290 |
Why?
| | Head Injuries, Penetrating | 1 | 2009 | 6 | 0.290 |
Why?
| | Outpatient Clinics, Hospital | 2 | 2020 | 80 | 0.290 |
Why?
| | Risk Assessment | 10 | 2021 | 3676 | 0.290 |
Why?
| | Abdominal Injuries | 2 | 2020 | 127 | 0.290 |
Why?
| | Safety-net Providers | 3 | 2019 | 126 | 0.280 |
Why?
| | Abdominal Abscess | 2 | 2020 | 25 | 0.280 |
Why?
| | Brain Injuries, Traumatic | 2 | 2026 | 441 | 0.280 |
Why?
| | Logistic Models | 4 | 2024 | 2119 | 0.280 |
Why?
| | Geriatric Assessment | 2 | 2020 | 233 | 0.270 |
Why?
| | Time Factors | 9 | 2020 | 7183 | 0.270 |
Why?
| | Multiple Trauma | 1 | 2009 | 116 | 0.270 |
Why?
| | Blood Coagulation Tests | 2 | 2018 | 70 | 0.260 |
Why?
| | Extravasation of Diagnostic and Therapeutic Materials | 2 | 2024 | 19 | 0.260 |
Why?
| | Education, Medical, Graduate | 2 | 2026 | 557 | 0.260 |
Why?
| | Emergency Service, Hospital | 5 | 2024 | 2313 | 0.260 |
Why?
| | Hospitals | 2 | 2022 | 732 | 0.260 |
Why?
| | Tomography, X-Ray Computed | 7 | 2026 | 2738 | 0.260 |
Why?
| | Blood Coagulation Disorders | 2 | 2021 | 189 | 0.250 |
Why?
| | Glasgow Coma Scale | 4 | 2026 | 213 | 0.250 |
Why?
| | Aorta | 3 | 2024 | 430 | 0.250 |
Why?
| | Wounds, Gunshot | 2 | 2017 | 258 | 0.250 |
Why?
| | Advanced Trauma Life Support Care | 1 | 2026 | 4 | 0.240 |
Why?
| | Triage | 1 | 2009 | 249 | 0.240 |
Why?
| | Quality Improvement | 4 | 2024 | 1291 | 0.230 |
Why?
| | Young Adult | 11 | 2023 | 14126 | 0.230 |
Why?
| | Choledocholithiasis | 2 | 2015 | 20 | 0.230 |
Why?
| | Brain Injuries | 2 | 2025 | 508 | 0.230 |
Why?
| | Blood Component Transfusion | 1 | 2026 | 103 | 0.220 |
Why?
| | Intracranial Hemorrhages | 1 | 2026 | 100 | 0.220 |
Why?
| | Facial Bones | 1 | 2025 | 28 | 0.220 |
Why?
| | Skull Fractures | 1 | 2025 | 35 | 0.220 |
Why?
| | Facial Injuries | 1 | 2025 | 25 | 0.220 |
Why?
| | Subarachnoid Hemorrhage, Traumatic | 1 | 2024 | 4 | 0.220 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2025 | 98 | 0.220 |
Why?
| | Cause of Death | 3 | 2017 | 472 | 0.220 |
Why?
| | Hepatic Artery | 1 | 2024 | 53 | 0.210 |
Why?
| | Hematoma | 1 | 2024 | 59 | 0.210 |
Why?
| | Wound Infection | 1 | 2025 | 57 | 0.210 |
Why?
| | Antibiotic Prophylaxis | 1 | 2025 | 129 | 0.200 |
Why?
| | Workload | 1 | 2025 | 170 | 0.200 |
Why?
| | Respiration, Artificial | 2 | 2026 | 708 | 0.200 |
Why?
| | Lung Injury | 1 | 2026 | 237 | 0.190 |
Why?
| | Venous Thrombosis | 1 | 2025 | 195 | 0.190 |
Why?
| | Adolescent | 7 | 2023 | 22453 | 0.190 |
Why?
| | Registries | 4 | 2024 | 2385 | 0.180 |
Why?
| | Pelvic Bones | 1 | 2024 | 135 | 0.180 |
Why?
| | Aged, 80 and over | 6 | 2020 | 8279 | 0.180 |
Why?
| | Health Plan Implementation | 2 | 2020 | 136 | 0.180 |
Why?
| | ROC Curve | 2 | 2022 | 615 | 0.180 |
Why?
| | Risk Factors | 8 | 2026 | 10792 | 0.180 |
Why?
| | Time Perception | 1 | 2022 | 33 | 0.170 |
Why?
| | Surveys and Questionnaires | 5 | 2023 | 6053 | 0.170 |
Why?
| | Patient Handoff | 1 | 2021 | 43 | 0.170 |
Why?
| | Paraspinal Muscles | 1 | 2021 | 13 | 0.170 |
Why?
| | Observational Studies as Topic | 1 | 2021 | 129 | 0.160 |
Why?
| | Liver Failure, Acute | 1 | 2021 | 67 | 0.160 |
Why?
| | Trauma Severity Indices | 1 | 2021 | 112 | 0.160 |
Why?
| | Altitude | 1 | 2025 | 473 | 0.160 |
Why?
| | Hospital Mortality | 6 | 2021 | 1031 | 0.160 |
Why?
| | General Surgery | 2 | 2020 | 207 | 0.160 |
Why?
| | Intubation, Intratracheal | 1 | 2023 | 320 | 0.160 |
Why?
| | Bias | 1 | 2021 | 202 | 0.160 |
Why?
| | Anesthetics, Local | 1 | 2021 | 100 | 0.160 |
Why?
| | Soft Tissue Infections | 1 | 2020 | 39 | 0.160 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2021 | 1721 | 0.160 |
Why?
| | United States Social Security Administration | 1 | 2019 | 2 | 0.160 |
Why?
| | Laparotomy | 1 | 2020 | 112 | 0.150 |
Why?
| | Diphenoxylate | 1 | 2019 | 5 | 0.150 |
Why?
| | Ileus | 1 | 2019 | 13 | 0.150 |
Why?
| | Loperamide | 1 | 2019 | 12 | 0.150 |
Why?
| | Metoclopramide | 1 | 2019 | 19 | 0.150 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2021 | 139 | 0.150 |
Why?
| | Erythromycin | 1 | 2019 | 20 | 0.150 |
Why?
| | Clinical Protocols | 2 | 2019 | 282 | 0.150 |
Why?
| | Fasciitis, Necrotizing | 1 | 2019 | 15 | 0.150 |
Why?
| | Mycoses | 1 | 2020 | 88 | 0.150 |
Why?
| | Diet Therapy | 1 | 2019 | 37 | 0.150 |
Why?
| | Antifungal Agents | 1 | 2020 | 149 | 0.150 |
Why?
| | Surgicenters | 1 | 2019 | 5 | 0.150 |
Why?
| | Fractures, Bone | 1 | 2024 | 415 | 0.150 |
Why?
| | Abdominal Wound Closure Techniques | 1 | 2018 | 8 | 0.140 |
Why?
| | Publishing | 1 | 2020 | 114 | 0.140 |
Why?
| | Education, Medical, Continuing | 1 | 2020 | 132 | 0.140 |
Why?
| | United States | 12 | 2025 | 15988 | 0.140 |
Why?
| | Viscoelastic Substances | 1 | 2018 | 9 | 0.140 |
Why?
| | Hospitals, University | 1 | 2019 | 176 | 0.140 |
Why?
| | Violence | 2 | 2023 | 281 | 0.140 |
Why?
| | Dabigatran | 1 | 2018 | 29 | 0.140 |
Why?
| | Pipecolic Acids | 1 | 2018 | 24 | 0.140 |
Why?
| | Conversion to Open Surgery | 1 | 2018 | 22 | 0.140 |
Why?
| | Program Evaluation | 2 | 2020 | 949 | 0.140 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2019 | 80 | 0.140 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2020 | 192 | 0.140 |
Why?
| | Diarrhea | 1 | 2019 | 192 | 0.140 |
Why?
| | Bandages | 1 | 2018 | 42 | 0.140 |
Why?
| | Photoperiod | 1 | 2018 | 55 | 0.140 |
Why?
| | Tertiary Care Centers | 1 | 2019 | 189 | 0.140 |
Why?
| | Surgical Wound Infection | 1 | 2021 | 316 | 0.140 |
Why?
| | Efficiency, Organizational | 1 | 2019 | 140 | 0.140 |
Why?
| | Antithrombins | 1 | 2018 | 70 | 0.140 |
Why?
| | Myocardial Contusions | 1 | 2017 | 2 | 0.130 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2020 | 237 | 0.130 |
Why?
| | Information Storage and Retrieval | 1 | 2018 | 121 | 0.130 |
Why?
| | Thorax | 1 | 2017 | 50 | 0.130 |
Why?
| | Sex Factors | 2 | 2021 | 2114 | 0.130 |
Why?
| | Multidetector Computed Tomography | 1 | 2017 | 40 | 0.130 |
Why?
| | Emergencies | 1 | 2018 | 176 | 0.130 |
Why?
| | Surgical Procedures, Operative | 1 | 2020 | 271 | 0.130 |
Why?
| | Thoracic Vertebrae | 1 | 2017 | 79 | 0.130 |
Why?
| | Tachycardia | 1 | 2017 | 57 | 0.130 |
Why?
| | Enteral Nutrition | 1 | 2019 | 216 | 0.130 |
Why?
| | Incidence | 3 | 2019 | 2883 | 0.130 |
Why?
| | Spinal Injuries | 1 | 2017 | 58 | 0.130 |
Why?
| | Blood Viscosity | 1 | 2016 | 18 | 0.130 |
Why?
| | Arginine | 1 | 2018 | 262 | 0.130 |
Why?
| | Heparin | 1 | 2018 | 244 | 0.130 |
Why?
| | Police | 1 | 2017 | 45 | 0.130 |
Why?
| | Occupational Injuries | 1 | 2017 | 46 | 0.130 |
Why?
| | Smartphone | 1 | 2018 | 102 | 0.130 |
Why?
| | Factor Xa Inhibitors | 1 | 2018 | 187 | 0.120 |
Why?
| | Electronic Health Records | 1 | 2025 | 1177 | 0.120 |
Why?
| | Accidental Falls | 1 | 2020 | 222 | 0.120 |
Why?
| | Photography | 1 | 2017 | 115 | 0.120 |
Why?
| | Cohort Studies | 3 | 2020 | 5965 | 0.120 |
Why?
| | Pelvis | 1 | 2017 | 124 | 0.120 |
Why?
| | Patient Transfer | 1 | 2019 | 206 | 0.120 |
Why?
| | Research Design | 1 | 2023 | 1137 | 0.120 |
Why?
| | Physical Therapy Modalities | 1 | 2020 | 332 | 0.120 |
Why?
| | Anti-Bacterial Agents | 2 | 2025 | 1915 | 0.120 |
Why?
| | Rivaroxaban | 1 | 2018 | 267 | 0.120 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 636 | 0.120 |
Why?
| | Blood Loss, Surgical | 1 | 2016 | 112 | 0.120 |
Why?
| | Blood Safety | 1 | 2015 | 11 | 0.120 |
Why?
| | Lumbar Vertebrae | 1 | 2017 | 252 | 0.120 |
Why?
| | Substance Abuse Detection | 1 | 2017 | 106 | 0.110 |
Why?
| | Radiography, Interventional | 1 | 2016 | 130 | 0.110 |
Why?
| | Platelet Transfusion | 1 | 2016 | 80 | 0.110 |
Why?
| | Medical Marijuana | 1 | 2017 | 123 | 0.110 |
Why?
| | Critical Care | 1 | 2021 | 697 | 0.110 |
Why?
| | Cryopreservation | 1 | 2015 | 110 | 0.110 |
Why?
| | Sulfonamides | 1 | 2018 | 581 | 0.110 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2018 | 497 | 0.100 |
Why?
| | Decision Support Systems, Clinical | 1 | 2018 | 265 | 0.100 |
Why?
| | Benchmarking | 1 | 2015 | 188 | 0.100 |
Why?
| | Exsanguination | 1 | 2013 | 19 | 0.100 |
Why?
| | Watchful Waiting | 2 | 2024 | 89 | 0.100 |
Why?
| | Angiography | 2 | 2024 | 208 | 0.100 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1540 | 0.100 |
Why?
| | Burn Units | 3 | 2019 | 48 | 0.100 |
Why?
| | International Cooperation | 1 | 2014 | 198 | 0.100 |
Why?
| | Erythrocyte Transfusion | 1 | 2015 | 231 | 0.100 |
Why?
| | Diagnostic Imaging | 1 | 2015 | 339 | 0.090 |
Why?
| | Patient Discharge | 1 | 2019 | 983 | 0.090 |
Why?
| | Chronic Pain | 1 | 2017 | 292 | 0.090 |
Why?
| | Decision Support Techniques | 1 | 2016 | 456 | 0.090 |
Why?
| | Age Factors | 5 | 2020 | 3335 | 0.090 |
Why?
| | Antifibrinolytic Agents | 1 | 2012 | 62 | 0.090 |
Why?
| | Blood Preservation | 1 | 2015 | 354 | 0.080 |
Why?
| | Educational Measurement | 2 | 2026 | 326 | 0.080 |
Why?
| | Suicide | 1 | 2018 | 720 | 0.080 |
Why?
| | Child Abuse | 1 | 2016 | 551 | 0.080 |
Why?
| | Surgical Mesh | 1 | 2010 | 50 | 0.080 |
Why?
| | Gastrointestinal Motility | 2 | 2019 | 29 | 0.080 |
Why?
| | Propensity Score | 2 | 2025 | 367 | 0.080 |
Why?
| | Malaria | 1 | 2010 | 73 | 0.070 |
Why?
| | Splanchnic Circulation | 1 | 2009 | 13 | 0.070 |
Why?
| | Tungsten | 1 | 2009 | 30 | 0.070 |
Why?
| | Xanthine Oxidase | 1 | 2009 | 79 | 0.070 |
Why?
| | Capillary Permeability | 1 | 2009 | 134 | 0.070 |
Why?
| | Survival Rate | 3 | 2020 | 2092 | 0.070 |
Why?
| | Follow-Up Studies | 4 | 2020 | 5417 | 0.070 |
Why?
| | Acute Disease | 2 | 2023 | 1031 | 0.070 |
Why?
| | Guideline Adherence | 2 | 2025 | 589 | 0.070 |
Why?
| | Databases, Factual | 3 | 2019 | 1486 | 0.070 |
Why?
| | Substance-Related Disorders | 1 | 2017 | 1094 | 0.060 |
Why?
| | Delivery of Health Care | 1 | 2014 | 947 | 0.060 |
Why?
| | Contusions | 1 | 2026 | 25 | 0.060 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 2 | 2021 | 219 | 0.060 |
Why?
| | Analysis of Variance | 2 | 2021 | 1311 | 0.060 |
Why?
| | Ultrasonography | 2 | 2023 | 770 | 0.060 |
Why?
| | Heparin, Low-Molecular-Weight | 1 | 2025 | 36 | 0.060 |
Why?
| | Combined Modality Therapy | 2 | 2020 | 1268 | 0.050 |
Why?
| | HIV Infections | 1 | 2019 | 3154 | 0.050 |
Why?
| | Neurosurgical Procedures | 1 | 2025 | 202 | 0.050 |
Why?
| | Radiology, Interventional | 1 | 2024 | 49 | 0.050 |
Why?
| | Common Bile Duct | 1 | 2023 | 14 | 0.050 |
Why?
| | Computed Tomography Angiography | 1 | 2024 | 145 | 0.050 |
Why?
| | Comorbidity | 2 | 2019 | 1660 | 0.050 |
Why?
| | Patient Acuity | 1 | 2023 | 47 | 0.050 |
Why?
| | Sex Chromosome Aberrations | 2 | 1982 | 69 | 0.050 |
Why?
| | Hypoxia | 1 | 2009 | 1199 | 0.040 |
Why?
| | Delphi Technique | 1 | 2023 | 331 | 0.040 |
Why?
| | Contrast Media | 1 | 2024 | 488 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5872 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2025 | 1990 | 0.040 |
Why?
| | Intensive Care Units | 1 | 2026 | 916 | 0.040 |
Why?
| | Antidiarrheals | 1 | 2019 | 12 | 0.040 |
Why?
| | Data Collection | 1 | 2022 | 635 | 0.040 |
Why?
| | Renal Replacement Therapy | 1 | 2020 | 100 | 0.040 |
Why?
| | Necrosis | 1 | 2020 | 244 | 0.040 |
Why?
| | Debridement | 1 | 2019 | 86 | 0.040 |
Why?
| | Early Medical Intervention | 1 | 2019 | 61 | 0.040 |
Why?
| | Europe | 1 | 2020 | 412 | 0.040 |
Why?
| | Gastrointestinal Agents | 1 | 2019 | 66 | 0.040 |
Why?
| | Morbidity | 1 | 2020 | 323 | 0.040 |
Why?
| | Population Dynamics | 1 | 2019 | 158 | 0.040 |
Why?
| | Fungi | 1 | 2020 | 161 | 0.040 |
Why?
| | Independent Living | 1 | 2020 | 114 | 0.040 |
Why?
| | Curriculum | 1 | 2026 | 1060 | 0.040 |
Why?
| | Acetaminophen | 1 | 2021 | 264 | 0.040 |
Why?
| | Organizational Innovation | 1 | 2019 | 120 | 0.040 |
Why?
| | Growth Disorders | 1 | 1979 | 86 | 0.030 |
Why?
| | Hospital Costs | 1 | 2019 | 124 | 0.030 |
Why?
| | Infant | 4 | 2023 | 10039 | 0.030 |
Why?
| | Safety | 1 | 2020 | 356 | 0.030 |
Why?
| | Prognosis | 2 | 2018 | 4293 | 0.030 |
Why?
| | California | 1 | 2019 | 475 | 0.030 |
Why?
| | Leadership | 1 | 2022 | 409 | 0.030 |
Why?
| | Child, Preschool | 4 | 2023 | 11799 | 0.030 |
Why?
| | Likelihood Functions | 1 | 2017 | 143 | 0.030 |
Why?
| | Homicide | 1 | 2017 | 68 | 0.030 |
Why?
| | Postural Balance | 1 | 2020 | 240 | 0.030 |
Why?
| | Probability | 1 | 2017 | 312 | 0.030 |
Why?
| | Burns, Chemical | 1 | 2016 | 32 | 0.030 |
Why?
| | Elasticity | 1 | 2016 | 184 | 0.030 |
Why?
| | Military Personnel | 1 | 2024 | 747 | 0.030 |
Why?
| | Counseling | 1 | 2019 | 408 | 0.030 |
Why?
| | Accidents, Traffic | 1 | 2017 | 191 | 0.030 |
Why?
| | Biliary Tract | 1 | 2015 | 14 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2015 | 62 | 0.030 |
Why?
| | Learning | 1 | 2020 | 452 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2020 | 1095 | 0.030 |
Why?
| | Self-Injurious Behavior | 1 | 2017 | 142 | 0.030 |
Why?
| | Societies, Medical | 1 | 2020 | 887 | 0.030 |
Why?
| | Liver Function Tests | 1 | 2015 | 106 | 0.030 |
Why?
| | Blood Banks | 1 | 2015 | 50 | 0.030 |
Why?
| | Age Distribution | 1 | 2016 | 403 | 0.030 |
Why?
| | Reference Values | 1 | 2017 | 798 | 0.030 |
Why?
| | Communication | 1 | 2021 | 967 | 0.030 |
Why?
| | Hospitals, Urban | 1 | 2015 | 144 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2020 | 603 | 0.030 |
Why?
| | Risk | 1 | 2017 | 911 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2017 | 255 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2015 | 427 | 0.030 |
Why?
| | Pain Measurement | 1 | 2017 | 555 | 0.030 |
Why?
| | Liver Diseases | 1 | 2017 | 304 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1890 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2017 | 1325 | 0.030 |
Why?
| | Survival Analysis | 1 | 2017 | 1385 | 0.020 |
Why?
| | India | 1 | 2014 | 218 | 0.020 |
Why?
| | Guatemala | 1 | 2014 | 345 | 0.020 |
Why?
| | Partial Thromboplastin Time | 1 | 2012 | 50 | 0.020 |
Why?
| | International Normalized Ratio | 1 | 2012 | 49 | 0.020 |
Why?
| | Platelet Count | 1 | 2012 | 96 | 0.020 |
Why?
| | Prevalence | 1 | 2019 | 2836 | 0.020 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2012 | 93 | 0.020 |
Why?
| | Fibrinolytic Agents | 1 | 2014 | 292 | 0.020 |
Why?
| | Child | 3 | 2023 | 22657 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2015 | 2029 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2023 | 3869 | 0.020 |
Why?
| | Alcoholism | 1 | 2017 | 817 | 0.020 |
Why?
| | Venules | 1 | 2009 | 14 | 0.020 |
Why?
| | Mesocricetus | 1 | 2009 | 46 | 0.020 |
Why?
| | Reperfusion | 1 | 2009 | 54 | 0.020 |
Why?
| | Cricetinae | 1 | 2009 | 304 | 0.020 |
Why?
| | Disease Progression | 1 | 2014 | 2852 | 0.020 |
Why?
| | Pregnancy | 1 | 2017 | 7191 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2009 | 2540 | 0.010 |
Why?
| | Luteinizing Hormone | 2 | 1982 | 190 | 0.010 |
Why?
| | Growth | 1 | 1982 | 49 | 0.010 |
Why?
| | Aneuploidy | 1 | 1982 | 91 | 0.010 |
Why?
| | Follicle Stimulating Hormone | 2 | 1982 | 249 | 0.010 |
Why?
| | Diet | 1 | 2009 | 1275 | 0.010 |
Why?
| | Rats | 1 | 2009 | 5614 | 0.010 |
Why?
| | Y Chromosome | 1 | 1979 | 36 | 0.010 |
Why?
| | X Chromosome | 1 | 1979 | 67 | 0.010 |
Why?
| | Bone Development | 1 | 1979 | 52 | 0.010 |
Why?
| | Intellectual Disability | 1 | 1979 | 175 | 0.010 |
Why?
| | Child Development | 1 | 1982 | 484 | 0.010 |
Why?
| | Infant, Newborn | 2 | 1982 | 6434 | 0.010 |
Why?
| | Animals | 1 | 2009 | 38109 | 0.000 |
Why?
| | Psychology, Child | 1 | 1982 | 37 | 0.000 |
Why?
| | Sexual Maturation | 1 | 1982 | 51 | 0.000 |
Why?
| | Body Height | 1 | 1982 | 202 | 0.000 |
Why?
| | Gonadal Steroid Hormones | 1 | 1982 | 144 | 0.000 |
Why?
| | Body Weight | 1 | 1982 | 978 | 0.000 |
Why?
| | Longitudinal Studies | 1 | 1982 | 2947 | 0.000 |
Why?
|
|
Cripps's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|